167 related articles for article (PubMed ID: 35786398)
1. Transcriptomic analysis identifies novel potential biomarkers and highlights cilium-related biological processes in the early stages of prion disease in mice.
Kim YC; Jeong BH
Prion; 2022 Dec; 16(1):84-90. PubMed ID: 35786398
[TBL] [Abstract][Full Text] [Related]
2. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
3. Central residues in prion protein PrP
Pasiana AD; Miyata H; Chida J; Hara H; Imamura M; Atarashi R; Sakaguchi S
J Biol Chem; 2022 Sep; 298(9):102381. PubMed ID: 35973512
[TBL] [Abstract][Full Text] [Related]
4. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
6. The first non-prion pathogen identified: neurotropic influenza virus.
Sakaguchi S; Hara H
Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
[TBL] [Abstract][Full Text] [Related]
7. Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus.
Benvegnù S; Roncaglia P; Agostini F; Casalone C; Corona C; Gustincich S; Legname G
Physiol Genomics; 2011 Jun; 43(12):711-25. PubMed ID: 21406608
[TBL] [Abstract][Full Text] [Related]
8. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
9. Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance.
Colini Baldeschi A; Zattoni M; Vanni S; Nikolic L; Ferracin C; La Sala G; Summa M; Bertorelli R; Bertozzi SM; Giachin G; Carloni P; Bolognesi ML; De Vivo M; Legname G
J Med Chem; 2022 Jul; 65(13):8998-9010. PubMed ID: 35771181
[TBL] [Abstract][Full Text] [Related]
10. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras.
Kupfer L; Eiden M; Buschmann A; Groschup MH
Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171
[TBL] [Abstract][Full Text] [Related]
11. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).
Mays CE; Armijo E; Morales R; Kramm C; Flores A; Tiwari A; Bian J; Telling GC; Pandita TK; Hunt CR; Soto C
J Biol Chem; 2019 Sep; 294(37):13619-13628. PubMed ID: 31320473
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the histo-molecular pathology of human prion disease.
Baiardi S; Rossi M; Capellari S; Parchi P
Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
[TBL] [Abstract][Full Text] [Related]
13. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
[TBL] [Abstract][Full Text] [Related]
14. Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis.
Singh A; Mohan ML; Isaac AO; Luo X; Petrak J; Vyoral D; Singh N
PLoS One; 2009; 4(2):e4468. PubMed ID: 19212444
[TBL] [Abstract][Full Text] [Related]
15. RNAi: a novel strategy for the treatment of prion diseases.
Kong Q
J Clin Invest; 2006 Dec; 116(12):3101-3. PubMed ID: 17143323
[TBL] [Abstract][Full Text] [Related]
16. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
17. Neuropathology of Animal Prion Diseases.
Orge L; Lima C; Machado C; Tavares P; Mendonça P; Carvalho P; Silva J; Pinto ML; Bastos E; Pereira JC; Gonçalves-Anjo N; Gama A; Esteves A; Alves A; Matos AC; Seixas F; Silva F; Pires I; Figueira L; Vieira-Pinto M; Sargo R; Pires MDA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801117
[TBL] [Abstract][Full Text] [Related]
18. Conformational conversion of prion protein in prion diseases.
Zhou Z; Xiao G
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591
[TBL] [Abstract][Full Text] [Related]
19. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
[TBL] [Abstract][Full Text] [Related]
20. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
Asante EA; Gowland I; Grimshaw A; Linehan JM; Smidak M; Houghton R; Osiguwa O; Tomlinson A; Joiner S; Brandner S; Wadsworth JDF; Collinge J
J Gen Virol; 2009 Mar; 90(Pt 3):546-558. PubMed ID: 19218199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
